Search

Vertex Bags Concert's Rival CF Drug For $160M, Plans Combo Studies

VERTEX BAGS CONCERT'S RIVAL CF DRUG FOR $160M, PLANS COMBO STUDIES

Concert Pharmaceuticals has been plugging away with an experimental cystic fibrosis drug that, if successful, might someday pose a...